1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs
Author(s)
Stopfer, LE; D'Souza, AD; White, FM
DownloadPublished version (781.0Kb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Quantitative mass-spectrometry-based methods to perform relative and absolute quantification of peptides in the immunopeptidome are growing in popularity as researchers aim to measure the dynamic nature of the peptide major histocompatibility complex repertoire and make copies-per-cell estimations of target antigens of interest. Multiple methods to carry out these experiments have been reported, each with unique advantages and limitations. This article describes existing methods and recent applications, offering guidance for improving quantitative accuracy and selecting an appropriate experimental set-up to maximize data quality and quantity.
Date issued
2021Department
Massachusetts Institute of Technology. Department of Biological EngineeringJournal
Immuno-Oncology and Technology
Publisher
Elsevier BV
Citation
Stopfer, LE, D'Souza, AD and White, FM. 2021. "1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs." Immuno-Oncology and Technology, 11.
Version: Final published version